665
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Risk of gastric carcinoma will be low in generations born at turn of the 20th and 21st centuries in Finland. Modelling NORDCAN data of the age group specific incidence rates of gastric cancer with PLS-regression and with attention to age (‘age effect’) and year of the birth (‘cohort effect’)

ORCID Icon, &
Pages 1271-1279 | Received 09 Apr 2023, Accepted 29 May 2023, Published online: 09 Jun 2023

References

  • NORDCAN–IARC https://www.kreftregisteret.no or https://www–dep.iarc.fr/nordcan/fi/frame.asp.
  • Statistics on cancer in Nordic countries. 2022. https://nordcan.iarc.fr/.
  • Wong MCS, Huang J, Chan PSF, et al. Global incidence and mortality of gastric cancer, 1980–2018. JAMA Netw Open. 2021;4(7):e2118457.
  • Lin Y, Zheng Y, Wang H–L, et al. Global patterns and trends in gastric incidence rates (1988–2012) and predictions to 2030. Gastroenterology. 2021;161(1):116–127.e8.
  • Sipponen P. Prevalence rates of heathy stomach mucosa, chronic non–atrophic and atrophic gastritis in endoscopic biopsies in adults born in Finland in 1890–1977. Scand J Gastroenterol. 2021;56(8):874–881.
  • Sipponen P, Sarna S, Vohlonen I. When will Helicobacter pylori gastritis disappear in history in Finland? Scand J Gastroenterol. 2022;57(2):154–157.
  • Helicobacter pylori IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241. PMCID: PMC7681621
  • Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19(Suppl 1):S37–S43.
  • Sipponen P. Helicobacter pylori: a cohort phenomenon. Am J Surg Pathol. 1995;19(Suppl 1):S30–S6.
  • Wold S, Sjöström M, Eriksson L. PLS–regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems. 2001;58(2):109–130.
  • Wold S, Ruhe H, Wold H, et al. The collinearity problem in linear regression. The partial squares approach to generalized inverses. SIAM J Sci and Stat Comput. 1984;5(3):735–743.
  • Eriksson L, Antti H, Gottfries J, et al. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem. 2004;380(3):419–429. .
  • Tu Y–K, Smith CG, Gilthorpe MS. A new approach to age–period–cohort analysis using partial least squares regression: the trend in blood pressure in the glasgow alumni cohort. PLoS One. 2011;6(4):e19401.
  • Pukkala E, Engholm G, Højsgaard Schmidt LK, et al. Nordic cancer registries–an overview of their procedures and data comparability. Acta Oncol. 2018;57(4):440–455.
  • Leinonen MK, Miettinen J, Heikkinen S, et al. Quality measures of the population–based finnish cancer registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–39.
  • Lumivero 2023. XLSTAT statistical and data analysis solution. New York, USA. https://www.xlstat.com/en.
  • Sipponen P, Helske T, Järvinen P, et al. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut. 1994;35(9):1167–1171.
  • Rehnberg–Laiho L, Rautelin H, Koskela P, et al. Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect. 2001;126(1):37–42.
  • Sonnenberg A. Epidemiology of Helicobacter pylori. Aliment Pharmacol Ther. 2022;55 Suppl 1(Suppl 1):S1–S13.
  • Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol. 1997;92(9):1480–1482.
  • Hooi JKY, Lai W, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta–analysis. Gastrtoenterology. 2017;53:420–429.
  • Sipponen P, Kekki M, Siurala M. The Sydney system: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol. 1991;6(3):244–251.
  • Sipponen P, Maaroos H–I. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657–667.
  • Correa P. Chronic gastritis: a clinico–pathological classification. Am J Gastroenterol. 1988;83(5):504–509.
  • Ihamäki T, Kekki M, Sipponen P, et al. The sequelae and course of chronic gastritis during a 30–to 34–year bioptic follow–up study. Scand J Gastroenterol. 1985;20(4):485–491.
  • Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161–1181.
  • Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345(8964):1525–1528.
  • Villako K, Maards H, Tammur R, et al. Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long–term follow–up examinations of a random sample. Endoscopy. 1990;22(3):114–117.
  • Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res. 1980;6:98–108.
  • Sipponen P, Kekki M, Haapakoski J, et al. Gastric cancer risk in chronic atrophic gastritis. Statistical calculations of cross-sectional data. Int J Cancer. 1985;35(2):173–177.
  • Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31:1104–1111.
  • Sipponen P, Kosunen TU, Valle J, et al. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol. 1992;45(4):319–323.
  • Komoto K, Haruma K, Kamada T, et al. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 1998;93(8):1271–1276.
  • Yusefi AR, Lankarani KB, Bastani P, et al. Risk factors for gastric cancer: a systematic review. Asian Pac J Cancer Prev. 2018;19:591–603.
  • Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
  • Moayyedi P, Axon ATR, Feltbower R, et al. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol. 2002;31(3):624–631.
  • Chapelle N, Manfredi S, Lepage C, et al. Trends in gastric cancer incidence: a period and birth cohort analysis in a well–defined French population. Gastric Cancer. 2016;19(2):682–682.
  • Sonnenberg A. Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut. 2010;59(6):736–743.
  • Wang C, Weber A, Graham DY. Age, period, and cohort effects on gastric cancer mortality. Dig Dis Sci. 2015;60(2):514–523.
  • Lin Y, Lin S, Chen J, et al. Time trends and age-period-cohort effects on the incidence of gastric cancer in Changle from 2003 to 2012. Cancer Manag Res. 2019;11:8885–8892.
  • Kuzmickiene I, Everatt R. Trends and age-period-cohort analysis of upper aerodigestive tract and stomach cancer mortality in Lithuania, 1987–2016. Public Health. 2021;196:62–68.
  • Luo G, Zhang Y, Guo P, et al. Global patterns and trends in stomach cancer incidence: age, period and birth cohort analysis. Int J Cancer. 2017;141(7):1333–1344.
  • Decarli A, La Vecchia C, Mezzanotte G, et al. Birth cohort, time, and age effects in Italian cancer mortality. Cancer. 1987;59(6):1221–1232.
  • Aragonés N, Pollán M, Rodero I, et al. Gastric cancer in the European union (1968–1992): mortality trends and cohort effect. Ann Epidemiol. 1997;7(4):294–303.
  • Okui T. An age-period-cohort analysis of mortality rates for stomach, colorectal, liver, and lung cancer among prefectures in Japan, 1999-2018. Environ Health Prev Med. 2020;25(1):80.
  • Seoane–Mato D, Aragonés N, Ferreras E, et al. Trends in oral cavity, pharyngeal, oesophageal, and gastric cancer mortality rates in Spain, 1952–2006: an age–period–cohort analysis. BMC Cancer. 2014;254(14):1–11.